GlassScriptPhysician profile
Jessica Li Johns
NPI 1841634342
$1,046.61
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $39.61 · 2021: $461 · 2022: $333 · 2023: $61.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $469.48 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $118.69 | 2021-2022 | |
| Hologic Sales and Service, LLC | $51.53 | 2019-2023 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $51.12 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $51.07 | 2021-2022 | |
| Abbvie INC. | $38.98 | 2019-2021 | |
| Organon LLC | $38.37 | 2022 | |
| Coopersurgical, INC. | $35.62 | 2019-2021 | |
| Covidien LP | $29.15 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.73 | 2022 | |
| Olympus America INC. | $22.37 | 2020 | |
| Radius Health, INC. | $22.36 | 2021 | |
| Evofem Biosciences, INC. | $20.04 | 2022 | |
| Roche Diagnostics Corporation | $19.83 | 2021 | |
| Therapeuticsmd, INC. | $18.56 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $18.47 | 2019 | |
| Daiichi Sankyo INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.